Efficacy analysis of ABT-414 with or without temozolomide (TMZ) in patients (pts) with EGFR-amplified, recurrent glioblastoma (rGBM) from a multicenter, international phase I clinical trial. Conference Paper uri icon

authors

  • Lassman, Andrew B
  • Van Den Bent, Martin J
  • Gan, Hui Kong
  • Reardon, David A
  • Kumthekar, Priya
  • Butowski, Nicholas A
  • Lwin, Zarnie
  • Mikkelsen, Tom
  • Nabors, Louis B
  • Papadopoulos, Kyriakos P
  • Penas-Prado, Marta
  • Simes, John
  • Wheeler, Helen
  • Gomez, Erica J
  • Lee, Ho-Jin
  • Roberts-Rapp, Lisa
  • Xiong, Hao
  • Bain, Earle E
  • Maag, David
  • Merrell, Ryan Thomas

publication date

  • 2017